Global Angina Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
SKU ID : QYR-21763441 | Publishing Date : 23-Sep-2022 | No. of pages : 96
Detailed TOC of Global Angina Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angina Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Beta Blockers
1.2.3 Calcium Antagonists
1.2.4 Anticoagulants
1.2.5 Antiplatelet
1.2.6 Nitrates
1.2.7 ACE Inhibitors
1.2.8 Ranolazine
1.3 Market by Application
1.3.1 Global Angina Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Angina Market Size (2017-2028)
2.2 Angina Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Angina Market Size by Region (2017-2022)
2.4 Global Angina Market Size Forecast by Region (2023-2028)
2.5 Global Top Angina Countries Ranking by Market Size
3 Angina Competitive by Company
3.1 Global Angina Revenue by Players
3.1.1 Global Angina Revenue by Players (2017-2022)
3.1.2 Global Angina Market Share by Players (2017-2022)
3.2 Global Angina Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Angina Revenue
3.4 Global Angina Market Concentration Ratio
3.4.1 Global Angina Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angina Revenue in 2021
3.5 Global Angina Key Players Head office and Area Served
3.6 Key Players Angina Product Solution and Service
3.7 Date of Enter into Angina Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Angina Breakdown Data by Type
4.1 Global Angina Historic Revenue by Type (2017-2022)
4.2 Global Angina Forecasted Revenue by Type (2023-2028)
5 Global Angina Breakdown Data by Application
5.1 Global Angina Historic Market Size by Application (2017-2022)
5.2 Global Angina Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Angina Revenue by Company (2020-2022)
6.2 North America Angina Revenue by Type (2017-2028)
6.3 North America Angina Revenue by Application (2017-2028)
6.4 North America Angina Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Angina Revenue by Company (2020-2022)
7.2 Europe Angina Revenue by Type (2017-2028)
7.3 Europe Angina Revenue by Application (2017-2028)
7.4 Europe Angina Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Angina Revenue by Company (2020-2022)
8.2 Asia Pacific Angina Revenue by Type (2017-2028)
8.3 Asia Pacific Angina Revenue by Application (2017-2028)
8.4 Asia Pacific Angina Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Angina Revenue by Company (2020-2022)
9.2 Latin America Angina Revenue by Type (2017-2028)
9.3 Latin America Angina Revenue by Application (2017-2028)
9.4 Latin America Angina Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Angina Revenue by Company (2020-2022)
10.2 Middle East and Africa Angina Revenue by Type (2017-2028)
10.3 Middle East and Africa Angina Revenue by Application (2017-2028)
10.4 Middle East and Africa Angina Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Angina Products and Services
11.1.4 Amgen Angina Revenue in Angina Business (2017-2022)
11.1.5 Amgen Angina SWOT Analysis
11.1.6 Amgen Recent Developments
11.2 Taxus Cardium Pharmaceuticals
11.2.1 Taxus Cardium Pharmaceuticals Company Details
11.2.2 Taxus Cardium Pharmaceuticals Business Overview
11.2.3 Taxus Cardium Pharmaceuticals Angina Products and Services
11.2.4 Taxus Cardium Pharmaceuticals Angina Revenue in Angina Business (2017-2022)
11.2.5 Taxus Cardium Pharmaceuticals Angina SWOT Analysis
11.2.6 Taxus Cardium Pharmaceuticals Recent Developments
11.3 LegoChem Biosciences
11.3.1 LegoChem Biosciences Company Details
11.3.2 LegoChem Biosciences Business Overview
11.3.3 LegoChem Biosciences Angina Products and Services
11.3.4 LegoChem Biosciences Angina Revenue in Angina Business (2017-2022)
11.3.5 LegoChem Biosciences Angina SWOT Analysis
11.3.6 LegoChem Biosciences Recent Developments
11.4 Lee’s Pharmaceutical
11.4.1 Lee’s Pharmaceutical Company Details
11.4.2 Lee’s Pharmaceutical Business Overview
11.4.3 Lee’s Pharmaceutical Angina Products and Services
11.4.4 Lee’s Pharmaceutical Angina Revenue in Angina Business (2017-2022)
11.4.5 Lee’s Pharmaceutical Angina SWOT Analysis
11.4.6 Lee’s Pharmaceutical Recent Developments
11.5 Milestone Pharmaceuticals
11.5.1 Milestone Pharmaceuticals Company Details
11.5.2 Milestone Pharmaceuticals Business Overview
11.5.3 Milestone Pharmaceuticals Angina Products and Services
11.5.4 Milestone Pharmaceuticals Angina Revenue in Angina Business (2017-2022)
11.5.5 Milestone Pharmaceuticals Angina SWOT Analysis
11.5.6 Milestone Pharmaceuticals Recent Developments
11.6 Juventas Therapeutics
11.6.1 Juventas Therapeutics Company Details
11.6.2 Juventas Therapeutics Business Overview
11.6.3 Juventas Therapeutics Angina Products and Services
11.6.4 Juventas Therapeutics Angina Revenue in Angina Business (2017-2022)
11.6.5 Juventas Therapeutics Angina SWOT Analysis
11.6.6 Juventas Therapeutics Recent Developments
11.7 ViroMed
11.7.1 ViroMed Company Details
11.7.2 ViroMed Business Overview
11.7.3 ViroMed Angina Products and Services
11.7.4 ViroMed Angina Revenue in Angina Business (2017-2022)
11.7.5 ViroMed Angina SWOT Analysis
11.7.6 ViroMed Recent Developments
11.8 Kuhnil Pharmaceutical
11.8.1 Kuhnil Pharmaceutical Company Details
11.8.2 Kuhnil Pharmaceutical Business Overview
11.8.3 Kuhnil Pharmaceutical Angina Products and Services
11.8.4 Kuhnil Pharmaceutical Angina Revenue in Angina Business (2017-2022)
11.8.5 Kuhnil Pharmaceutical Angina SWOT Analysis
11.8.6 Kuhnil Pharmaceutical Recent Developments
12 Angina Market Dynamics
12.1 Angina Market Trends
12.2 Angina Market Drivers
12.3 Angina Market Challenges
12.4 Angina Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures, Tables and Charts Available in Global Angina Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
List of TablesTable 1. Global Angina Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Beta Blockers
Table 3. Key Players of Calcium Antagonists
Table 4. Key Players of Anticoagulants
Table 5. Key Players of Antiplatelet
Table 6. Key Players of Nitrates
Table 7. Key Players of ACE Inhibitors
Table 8. Key Players of Ranolazine
Table 9. Global Angina Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Angina Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 11. Global Angina Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Angina Revenue Market Share by Region (2017-2022)
Table 13. Global Angina Revenue by Players (2017-2022) & (US$ Million)
Table 14. Global Angina Market Share by Players (2017-2022)
Table 15. Global Top Angina Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angina as of 2021)
Table 16. Ranking of Global Top Angina Companies by Revenue (US$ Million) in 2021
Table 17. Global 5 Largest Players Market Share by Angina Revenue (CR5 and HHI) & (2017-2022)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Angina Product Solution and Service
Table 20. Date of Key Manufacturers Enter into Angina Market
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Angina Market Size by Type (2017-2022) & (US$ Million)
Table 23. Global Angina Revenue Market Share by Type (2017-2022)
Table 24. Global Angina Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 25. Global Angina Revenue Market Share by Type (2023-2028)
Table 26. Global Angina Market Size by Application (2017-2022) & (US$ Million)
Table 27. Global Angina Revenue Market Share by Application (2017-2022)
Table 28. Global Angina Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 29. Global Angina Revenue Market Share by Application (2023-2028)
Table 30. North America Angina Revenue by Company (2020-2022) & (US$ Million)
Table 31. North America Angina Revenue by Type (2017-2022) & (US$ Million)
Table 32. North America Angina Revenue by Type (2023-2028) & (US$ Million)
Table 33. North America Angina Revenue by Application (2017-2022) & (US$ Million)
Table 34. North America Angina Revenue by Application (2023-2028) & (US$ Million)
Table 35. North America Angina Revenue by Country (2017-2022) & (US$ Million)
Table 36. North America Angina Revenue by Country (2023-2028) & (US$ Million)
Table 37. Europe Angina Revenue by Company (2020-2022) & (US$ Million)
Table 38. Europe Angina Revenue by Type (2017-2022) & (US$ Million)
Table 39. Europe Angina Revenue by Type (2023-2028) & (US$ Million)
Table 40. Europe Angina Revenue by Application (2017-2022) & (US$ Million)
Table 41. Europe Angina Revenue by Application (2023-2028) & (US$ Million)
Table 42. Europe Angina Revenue by Country (2017-2022) & (US$ Million)
Table 43. Europe Angina Revenue by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Angina Revenue by Company (2020-2022) & (US$ Million)
Table 45. Asia Pacific Angina Revenue by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Angina Revenue by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Angina Revenue by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Angina Revenue by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Angina Revenue by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Angina Revenue by Region (2023-2028) & (US$ Million)
Table 51. Latin America Angina Revenue by Company (2020-2022) & (US$ Million)
Table 52. Latin America Angina Revenue by Type (2017-2022) & (US$ Million)
Table 53. Latin America Angina Revenue by Type (2023-2028) & (US$ Million)
Table 54. Latin America Angina Revenue by Application (2017-2022) & (US$ Million)
Table 55. Latin America Angina Revenue by Application (2023-2028) & (US$ Million)
Table 56. Latin America Angina Revenue by Country (2017-2022) & (US$ Million)
Table 57. Latin America Angina Revenue by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Angina Revenue by Company (2020-2022) & (US$ Million)
Table 59. Middle East and Africa Angina Revenue by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Angina Revenue by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Angina Revenue by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Angina Revenue by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Angina Revenue by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Angina Revenue by Country (2023-2028) & (US$ Million)
Table 65. Amgen Company Details
Table 66. Amgen Business Overview
Table 67. Amgen Angina Product and Services
Table 68. Amgen Angina Revenue in Angina Business (2017-2022) & (US$ Million)
Table 69. Amgen Angina SWOT Analysis
Table 70. Amgen Recent Developments
Table 71. Taxus Cardium Pharmaceuticals Company Details
Table 72. Taxus Cardium Pharmaceuticals Business Overview
Table 73. Taxus Cardium Pharmaceuticals Angina Product and Services
Table 74. Taxus Cardium Pharmaceuticals Angina Revenue in Angina Business (2017-2022) & (US$ Million)
Table 75. Taxus Cardium Pharmaceuticals Angina SWOT Analysis
Table 76. Taxus Cardium Pharmaceuticals Recent Developments
Table 77. LegoChem Biosciences Company Details
Table 78. LegoChem Biosciences Business Overview
Table 79. LegoChem Biosciences Angina Product and Services
Table 80. LegoChem Biosciences Angina Revenue in Angina Business (2017-2022) & (US$ Million)
Table 81. LegoChem Biosciences Angina SWOT Analysis
Table 82. LegoChem Biosciences Recent Developments
Table 83. Lee’s Pharmaceutical Company Details
Table 84. Lee’s Pharmaceutical Business Overview
Table 85. Lee’s Pharmaceutical Angina Product and Services
Table 86. Lee’s Pharmaceutical Angina Revenue in Angina Business (2017-2022) & (US$ Million)
Table 87. Lee’s Pharmaceutical Angina SWOT Analysis
Table 88. Lee’s Pharmaceutical Recent Developments
Table 89. Milestone Pharmaceuticals Company Details
Table 90. Milestone Pharmaceuticals Business Overview
Table 91. Milestone Pharmaceuticals Angina Product and Services
Table 92. Milestone Pharmaceuticals Angina Revenue in Angina Business (2017-2022) & (US$ Million)
Table 93. Milestone Pharmaceuticals Angina SWOT Analysis
Table 94. Milestone Pharmaceuticals Recent Developments
Table 95. Juventas Therapeutics Company Details
Table 96. Juventas Therapeutics Business Overview
Table 97. Juventas Therapeutics Angina Product and Services
Table 98. Juventas Therapeutics Angina Revenue in Angina Business (2017-2022) & (US$ Million)
Table 99. Juventas Therapeutics Angina SWOT Analysis
Table 100. Juventas Therapeutics Recent Developments
Table 101. ViroMed Company Details
Table 102. ViroMed Business Overview
Table 103. ViroMed Angina Product and Services
Table 104. ViroMed Angina Revenue in Angina Business (2017-2022) & (US$ Million)
Table 105. ViroMed Angina SWOT Analysis
Table 106. ViroMed Recent Developments
Table 107. Kuhnil Pharmaceutical Company Details
Table 108. Kuhnil Pharmaceutical Business Overview
Table 109. Kuhnil Pharmaceutical Angina Product and Services
Table 110. Kuhnil Pharmaceutical Angina Revenue in Angina Business (2017-2022) & (US$ Million)
Table 111. Kuhnil Pharmaceutical Angina SWOT Analysis
Table 112. Kuhnil Pharmaceutical Recent Developments
Table 113. Angina Market Trends
Table 114. Angina Market Drivers
Table 115. Angina Market Challenges
Table 116. Angina Market Restraints
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Angina Sales Market Share by Type: 2021 VS 2028
Figure 2. Beta Blockers Features
Figure 3. Calcium Antagonists Features
Figure 4. Anticoagulants Features
Figure 5. Antiplatelet Features
Figure 6. Nitrates Features
Figure 7. ACE Inhibitors Features
Figure 8. Ranolazine Features
Figure 9. Global Angina Sales Market Share by Application: 2021 VS 2028
Figure 10. Clinics Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Other Case Studies
Figure 13. Angina Report Years Considered
Figure 14. Global Angina Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Angina Market Size 2017-2028 (US$ Million)
Figure 16. Global Angina Market Size Market Share by Region: 2021 VS 2028
Figure 17. Global Angina Revenue Market Share by Region in 2017 VS 2022
Figure 18. Global Top 10 Angina Countries Ranking by Market Size (US$ Million) in 2021
Figure 19. Global Angina Market Share by Players in 2021
Figure 20. Global Top Angina Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angina as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Angina Revenue in 2021
Figure 22. North America Angina Revenue Market Share by Company in 2021
Figure 23. North America Angina Revenue Market Share by Type (2017-2028)
Figure 24. North America Angina Revenue Market Share by Application (2017-2028)
Figure 25. North America Angina Revenue Share by Country (2017-2028)
Figure 26. U.S. Angina Revenue (2017-2028) & (US$ Million)
Figure 27. Canada Angina Revenue (2017-2028) & (US$ Million)
Figure 28. Europe Angina Revenue Market Share by Company in 2021
Figure 29. Europe Angina Revenue Market Share by Type (2017-2028)
Figure 30. Europe Angina Revenue Market Share by Application (2017-2028)
Figure 31. Europe Angina Revenue Share by Country (2017-2028)
Figure 32. Germany Angina Revenue (2017-2028) & (US$ Million)
Figure 33. France Angina Revenue (2017-2028) & (US$ Million)
Figure 34. U.K. Angina Revenue (2017-2028) & (US$ Million)
Figure 35. Italy Angina Revenue (2017-2028) & (US$ Million)
Figure 36. Russia Angina Revenue (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Angina Revenue Market Share by Company in 2021
Figure 38. Asia Pacific Angina Revenue Market Share by Type (2017-2028)
Figure 39. Asia Pacific Angina Revenue Market Share by Application (2017-2028)
Figure 40. Asia Pacific Angina Revenue Share by Region (2017-2028)
Figure 41. China Angina Revenue (2017-2028) & (US$ Million)
Figure 42. Japan Angina Revenue (2017-2028) & (US$ Million)
Figure 43. South Korea Angina Revenue (2017-2028) & (US$ Million)
Figure 44. India Angina Revenue (2017-2028) & (US$ Million)
Figure 45. Australia Angina Revenue (2017-2028) & (US$ Million)
Figure 46. Taiwan Angina Revenue (2017-2028) & (US$ Million)
Figure 47. Indonesia Angina Revenue (2017-2028) & (US$ Million)
Figure 48. Thailand Angina Revenue (2017-2028) & (US$ Million)
Figure 49. Malaysia Angina Revenue (2017-2028) & (US$ Million)
Figure 50. Philippines Angina Revenue (2017-2028) & (US$ Million)
Figure 51. Vietnam Angina Revenue (2017-2028) & (US$ Million)
Figure 52. Latin America Angina Revenue Market Share by Company in 2021
Figure 53. Latin America Angina Revenue Market Share by Type (2017-2028)
Figure 54. Latin America Angina Revenue Market Share by Application (2017-2028)
Figure 55. Latin America Angina Revenue Share by Country (2017-2028)
Figure 56. Mexico Angina Revenue (2017-2028) & (US$ Million)
Figure 57. Brazil Angina Revenue (2017-2028) & (US$ Million)
Figure 58. Argentina Angina Revenue (2017-2028) & (US$ Million)
Figure 59. Middle East and Africa Angina Revenue Market Share by Company in 2021
Figure 60. Middle East and Africa Angina Revenue Market Share by Type (2017-2028)
Figure 61. Middle East and Africa Angina Revenue Market Share by Application (2017-2028)
Figure 62. Middle East and Africa Angina Revenue Share by Country (2017-2028)
Figure 63. Turkey Angina Revenue (2017-2028) & (US$ Million)
Figure 64. Saudi Arabia Angina Revenue (2017-2028) & (US$ Million)
Figure 65. U.A.E Angina Revenue (2017-2028) & (US$ Million)
Figure 66. Amgen Revenue Growth Rate in Angina Business (2017-2022)
Figure 67. Taxus Cardium Pharmaceuticals Revenue Growth Rate in Angina Business (2017-2022)
Figure 68. LegoChem Biosciences Revenue Growth Rate in Angina Business (2017-2022)
Figure 69. Lee’s Pharmaceutical Revenue Growth Rate in Angina Business (2017-2022)
Figure 70. Milestone Pharmaceuticals Revenue Growth Rate in Angina Business (2017-2022)
Figure 71. Juventas Therapeutics Revenue Growth Rate in Angina Business (2017-2022)
Figure 72. ViroMed Revenue Growth Rate in Angina Business (2017-2022)
Figure 73. Kuhnil Pharmaceutical Revenue Growth Rate in Angina Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Keyplayers in Global Angina Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
AmgenTaxus Cardium Pharmaceuticals
LegoChem Biosciences
Lee’s Pharmaceutical
Milestone Pharmaceuticals
Juventas Therapeutics
ViroMed
Kuhnil Pharmaceutical